Join
Live feed
·
PRReleasevia Quantisnow
Chemomab Therapeutics Ltd. logo

Chemomab Therapeutics Announces Nebokitug Phase 2 SPRING Trial Results in Primary Sclerosing Cholangitis Published in the American Journal of Gastroenterology

ByQuantisnow·Wall Street's wire, on your screen.
CMMB· Chemomab Therapeutics Ltd.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CMMB (Chemomab Therapeutics Ltd.) and more on Quantisnow.